Study to Evaluate Efficacy and Safety of Entelon 50mg in Patients With Non-Proliferative Diabetic Retinopathy

NCT05358080 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

396

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Proliferative Diabetic Retinopathy

Interventions

DRUG: Entelon Tab. 50mg
DRUG: Placebo

Sponsor

Hanlim Pharm. Co., Ltd.